TSPAN7 and chronic myelogenous leukemia, BCR-ABL1 positive: Increased levels of TSPAN7 in patients with acute lymphoblastic leukemia, chronic myeloid leukemia, or acute myeloid leukemia are associated with drug resistance [53].